Safety and efficacy of adaptive servo-ventilation in patients with severe systolic heart failure

Abstract Background and purpose It is unclear whether adaptive servo-ventilation (ASV) is safe and effective in patients with severe systolic heart failure (HF). Our aim in this study was to estimate the safety and efficacy of ASV therapy for patients with severe systolic HF. Methods and subjects Se...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiology 2014-04, Vol.63 (4), p.302-307
Main Authors: Takama, Noriaki, MD, PhD, Kurabayashi, Masahiko, MD, PhD, FJCC
Format: Article
Language:English
Subjects:
Adaptive servo-ventilation
Aged
Aged, 80 and over
Biomarkers - blood
Cardiovascular
Cardiovascular Diseases - epidemiology
Female
Heart failure
Heart Failure - therapy
Heart Failure, Systolic - diagnosis
Heart Failure, Systolic - physiopathology
Heart Failure, Systolic - therapy
Humans
Incidence
Male
Middle Aged
Natriuretic Peptide, Brain - blood
Respiration, Artificial - methods
Safety
Severity of Illness Index
Sleep-disordered breathing
Stroke Volume
Time Factors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background and purpose It is unclear whether adaptive servo-ventilation (ASV) is safe and effective in patients with severe systolic heart failure (HF). Our aim in this study was to estimate the safety and efficacy of ASV therapy for patients with severe systolic HF. Methods and subjects Seventy-six HF patients (age: 69 ± 12 years; 53 men), categorized as New York Heart Association (NYHA) Class II–IV, with left ventricular ejection fraction (LVEF) of
ISSN:0914-5087
1876-4738
DOI:10.1016/j.jjcc.2013.09.008